Basic information
Biomarker: PIR2
Histology type: endometrial carcinoma
Cohort characteristics
Country: UK
Region: Manchester
Followed up time :
Subgroup 1 name : malignant
Subgroup 1 number: 14
Subgroup 2 name: normaL
Subgroup 2 number: 8
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 22 | malignant | 14 | norma | 8 |
Sample information
Conclusion: Substantiate PIR2/RNF144B as a novel candidate for targeted therapy in endometrial cancer.Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation
Sample type : tissue
Sample method: western blotting/IHC/Immunohistochemistry
Expression pattern : PIR2/RNF144B
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
